These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22146238)

  • 21. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.
    Gumprecht J; Gosho M; Budinski D; Hounslow N
    Diabetes Obes Metab; 2011 Nov; 13(11):1047-55. PubMed ID: 21812889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized placebo controlled trial of early treatment of acute ischemic stroke with atorvastatin and irbesartan.
    Beer C; Blacker D; Bynevelt M; Hankey GJ; Puddey IB
    Int J Stroke; 2012 Feb; 7(2):104-11. PubMed ID: 22044557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation cardioprotective effects of atorvastatin in rats by real time myocardial contrast echocardiography.
    Filusch A; Buss S; Hardt S; Katus HA; Kuecherer HF; Hansen A
    Echocardiography; 2008 Oct; 25(9):974-81. PubMed ID: 18771549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous oral administration of atorvastatin ameliorates brain damage after transient focal ischemia in rats.
    Saito T; Nito C; Ueda M; Inaba T; Kamiya F; Muraga K; Katsura K; Katayama Y
    Life Sci; 2014 Jan; 94(2):106-14. PubMed ID: 24333133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure.
    Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Pitsavos C; Vlachopoulos C; Panagiotakos D; Stefanadis C
    Atherosclerosis; 2005 Feb; 178(2):359-63. PubMed ID: 15694946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trial.
    Hernández C; Francisco G; Ciudin A; Chacón P; Montoro B; Llaverias G; Blanco-Vaca F; Simó R
    Diabetes Metab; 2011 Apr; 37(2):124-30. PubMed ID: 21131223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin.
    Krauss RM; Pinto CA; Liu Y; Johnson-Levonas AO; Dansky HM
    J Clin Lipidol; 2015; 9(1):93-102. PubMed ID: 25670366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
    Mohler ER; Hiatt WR; Creager MA
    Circulation; 2003 Sep; 108(12):1481-6. PubMed ID: 12952839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
    Diabetes Atorvastin Lipid Intervention (DALI) Study Group
    Diabetes Care; 2001 Aug; 24(8):1335-41. PubMed ID: 11473066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats.
    Prakash P; Khanna V; Singh V; Jyoti A; Jain M; Keshari RS; Barthwal MK; Dikshit M
    Cardiovasc Drugs Ther; 2011 Aug; 25(4):285-97. PubMed ID: 21671014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The atorvastatin during ischemic stroke study: a pilot randomized controlled trial.
    Muscari A; Puddu GM; Santoro N; Serafini C; Cenni A; Rossi V; Zoli M
    Clin Neuropharmacol; 2011; 34(4):141-7. PubMed ID: 21677574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atorvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in rats.
    Wu K; Lei W; Tian J; Li H
    BMC Nephrol; 2014 Jan; 15():14. PubMed ID: 24423094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX; Cubeddu RJ; Heimowitz T; Restrepo B; Lamas GA; Weinberg GB
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
    Liu M; Wang F; Wang Y; Jin R
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin.
    Sirtori CR; Calabresi L; Pisciotta L; Cattin L; Pauciullo P; Montagnani M; Manzato E; Bittolo Bon G; Fellin R
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):47-55. PubMed ID: 15871851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients.
    Thallinger C; Urbauer E; Lackner E; Graselli U; Kostner K; Wolzt M; Joukhadar C
    Int J Clin Pharmacol Ther; 2005 Dec; 43(12):551-7. PubMed ID: 16372516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
    Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
    Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
    Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.